LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity-Reference-Cited by-同舟云学术

LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity

Published:2020-06 Issue:1 Volume:391 Page:111984
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Wang Hui,Cai Jun,Du Shaoxia,Wei Wei,Shen Xiaohong

Funder

National Natural Science Foundation of China

Tianjin Medical University

Publisher

Elsevier BV

Subject

Cell Biology

Reference51 articles.

1. Schneider, G., et al., Pancreatic cancer: basic and clinical aspects. 128(6): p. 1606-1625.

2. Stathis, A. and M.J. Moore, Advanced pancreatic carcinoma: current treatment and future challenges. Nat. Rev. Clin. Oncol.. 7(3): p. 163-172.

3. Desmoplasia of pancreatic ductal adenocarcinoma;Pandol;Clin. Gastroenterol. Hepatol.,2009

4. Bhaw-Luximon, A. and D. Jhurry, New avenues for improving Pancreatic Ductal Adenocarcinoma (PDAC) treatment: selective stroma depletion combined with nano drug delivery. Canc. Lett.. 369(2): p. S030438351500587X.

5. Form and function: the laminin family of heterotrimers;Colognato;Dev. Dynam.,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters;Journal of Advanced Research;2024-09

2. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway;Molecular Medicine;2024-05-17

3. Oncogenic Roles of Laminin Subunit Gamma‐2 in Intrahepatic Cholangiocarcinoma via Promoting EGFR Translation;Advanced Science;2024-03-25

4. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches;Environmental Research;2024-01

5. Immuno-oncologic signature of malignant transformation in oral squamous cell carcinoma;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-11